Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials.
Zongguo YangXian LiaoYunfei LuQingnian XuBozong TangXiaorong ChenYongchun YuPublished in: Evidence-based complementary and alternative medicine : eCAM (2017)
Add-on therapy with TCM could improve overall survival, increase clinical tumor responses, lead to better QOL, and reduce adverse events in hepatocellular carcinoma.